Company Filing History:
1 out of 832,843 Years Active: 2021-2024
Title: Innovations of Chun Loong Ho in Therapeutic Probiotics
Introduction
Chun Loong Ho is an innovative inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in developing therapeutic systems aimed at combating colorectal cancer. With a total of 2 patents, his work showcases the intersection of genetic engineering and dietary science.
Latest Patents
One of Chun Loong Ho's latest patents is an engineered therapeutic probiotic system and method. This invention provides therapeutic and protective measures against colorectal cancer by utilizing genetically modified gut bacteria in conjunction with an optimized diet high in cruciferous vegetable intake. The claimed system maximizes the therapeutic value of the cruciferous vegetable diet to eradicate, offset, or prophylactically prevent the onset of colorectal cancer. The engineered gut bacteria bind specifically to the heparan sulphate proteoglycan on colorectal cancer cells, secreting the enzyme myrosinase. This enzyme transforms host-ingested glucosinolates, which are natural components of cruciferous vegetables, into sulphoraphane, an organic small molecule known for its anti-cancer activity.
Career Highlights
Chun Loong Ho has established himself as a prominent figure in the field of biotechnology. His innovative approaches to health and nutrition have garnered attention and respect within the scientific community. His work not only addresses critical health issues but also opens new avenues for research and development in therapeutic applications.
Collaborations
Chun Loong Ho collaborates with Matthew Wook Chang, who is also a notable figure in the field. Their partnership exemplifies the importance of teamwork in advancing scientific research and innovation.
Conclusion
Chun Loong Ho's contributions to the field of therapeutic probiotics highlight the potential of genetic engineering in addressing serious health challenges. His innovative work continues to inspire further research and development in the fight against colorectal cancer.